22-17120349-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031890.4(TMEM121B):c.779C>T(p.Ala260Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,531,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031890.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM121B | NM_031890.4 | c.779C>T | p.Ala260Val | missense_variant | 1/1 | ENST00000331437.4 | NP_114096.1 | |
TMEM121B | XM_011546124.3 | c.779C>T | p.Ala260Val | missense_variant | 1/2 | XP_011544426.1 | ||
TMEM121B | NM_001163079.2 | c.-81-206C>T | intron_variant | NP_001156551.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM121B | ENST00000331437.4 | c.779C>T | p.Ala260Val | missense_variant | 1/1 | NM_031890.4 | ENSP00000329318 | P1 | ||
TMEM121B | ENST00000399875.1 | c.-81-206C>T | intron_variant | 2 | ENSP00000382764 |
Frequencies
GnomAD3 genomes AF: 0.000259 AC: 39AN: 150620Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000154 AC: 27AN: 174904Hom.: 0 AF XY: 0.000130 AC XY: 13AN XY: 99944
GnomAD4 exome AF: 0.000113 AC: 156AN: 1380630Hom.: 0 Cov.: 36 AF XY: 0.000113 AC XY: 78AN XY: 687238
GnomAD4 genome AF: 0.000259 AC: 39AN: 150620Hom.: 0 Cov.: 33 AF XY: 0.000218 AC XY: 16AN XY: 73512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.779C>T (p.A260V) alteration is located in exon 1 (coding exon 1) of the CECR6 gene. This alteration results from a C to T substitution at nucleotide position 779, causing the alanine (A) at amino acid position 260 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at